← Leaderboards
Chintan Parekh
Children'S Hospital Of Los Angeles
$3,618,862
Attributed
$4,860,564
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,860,564 · 2
By mechanism
R01$4,860,564 · 2
Top collaborators
- Gay Miriam Crooks3 shared
Most similar at Children'S Hospital Of Los Angeles
Same institution · by research overlap
- Chester Koh$3,383,865
- Laura Perin$5,029,089
Others in their field
Other Emerging Leaders on “Production”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$451,761,218
- Sonia M Thomas · Research Triangle Institute$451,761,218
- Leonard Freedman · Leidos Biomedical Research, Inc.$239,520,687
- Lynn Briscoe · Leidos Biomedical Research, Inc.$108,384,076
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
Research focus
ProductionNotch1 GeneGenesOverexpressionLoss Of FunctionMouse ModelFightingGenerationsInfectionHematopoietic Stem CellsKnock-DownLeukocytesMature T-LymphocyteMediatingChromatinEpigenetic ProcessBindingCellsAnti-CancerGenetic TranscriptionCancer CellChimeric Antigen ReceptorInsightProgenitor
Grant awards (9)
The role of BCL11B in T lineage fate during human thymopoiesis and pluripotent stem cell differentiation$818,621
R01 · FY2025 · AI
BCL11B activation as an approach for enhancing the efficacy of immunotherapy$490,646
R01 · FY2025 · AI · contact PI
The role of BCL11B in T lineage fate during human thymopoiesis and pluripotent stem cell differentiation$818,795
R01 · FY2024 · AI
BCL11B activation as an approach for enhancing the efficacy of immunotherapy$320,400
R01 · FY2024 · AI · contact PI
BCL11B activation as an approach for enhancing the efficacy of immunotherapy$169,353
R01 · FY2024 · AI · contact PI
The role of BCL11B in T lineage fate during human thymopoiesis and pluripotent stem cell differentiation$845,988
R01 · FY2023 · AI
BCL11B activation as an approach for enhancing the efficacy of immunotherapy$499,162
R01 · FY2023 · AI · contact PI
BCL11B activation as an approach for enhancing the efficacy of immunotherapy$461,674
R01 · FY2022 · AI · contact PI
BCL11B activation as an approach for enhancing the efficacy of immunotherapy$435,925
R01 · FY2021 · AI · contact PI